2. Academic Validation
  3. Targeting Human Carbonic Anhydrases with Novel Piperazine and Homopiperazine Benzenesulfonamides to Alleviate Paclitaxel-Induced Peripheral Neuropathy

Targeting Human Carbonic Anhydrases with Novel Piperazine and Homopiperazine Benzenesulfonamides to Alleviate Paclitaxel-Induced Peripheral Neuropathy

  • J Med Chem. 2025 Dec 11;68(23):25485-25504. doi: 10.1021/acs.jmedchem.5c02626.
Laura Micheli 1,  Andrea Angeli 2,  Lorenzo Di Cesare Mannelli 1,  Carla Ghelardini 1,  Marta Ferraroni 3,  Rudolfs Barons 4 5,  Raivis Zalubovskis 4 5,  Susi Zara 6,  Simone Carradori 6,  Claudiu T Supuran 2
Affiliations

Affiliations

  • 1 Pharmacology and Toxicology Section, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, viale Gaetano Pieraccini 6, Firenze, Florence 50139, Italy.
  • 2 NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, Florence 50019, Italy.
  • 3 Department of Chemistry "Ugo Schiff", University of Florence, Via della Lastruccia 3-13, Sesto Fiorentino, Florence I-50019, Italy.
  • 4 Latvian Institute of Organic Synthesis, Riga LV-1006, Latvia.
  • 5 Institute of Chemistry and Chemical Technology, Faculty of Natural Sciences and Technology, Riga Technical University, Riga LV-1048, Latvia.
  • 6 Department of Pharmacy, "G. d'Annunzio" University of Chieti-Pescara, Chieti 66100, Italy.
PMID: 41307493 DOI: 10.1021/acs.jmedchem.5c02626
Abstract

In this study, we developed novel Carbonic Anhydrase (CA) inhibitors potentially useful in managing paclitaxel-induced peripheral neuropathy. A total of 64 new compounds were synthesized and evaluated for in vitro inhibitory activity against hCAs showing interesting inhibition activity against hCA II, hCA VA, and hCA VII, the main isoforms implicated in this pathology. X-ray crystallographic analysis of compounds 9a, 11a, 13a, and 24a on hCA II revealed, for the first time, distinct orientations of piperazine and homopiperazine rings within the active site. In vivo testing of the most promising derivatives (9a, 11a, 13a, and 20a) demonstrated significant pain relieving effects in a mouse model of paclitaxel-induced peripheral neuropathy, with potent and sustained activity lasting up to 90 min postadministration. Notably, compound 13a produced antihypersensitivity effects at a dose 33-fold lower than reference drugs such as acetazolamide and gabapentin.

Figures
Products